youtube_live
Q3 2026 earnings • in 4 days
See detailschevron_right
HNGE:NYSE
Hinge Health Inc
$116.79
arrow_upward
+1.31%(+1.51) 1D
Oct 29, 2:55:16 PM GMT-4 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HNGE...
Open
$114.09
High
$117.46
Low
$113.56
Mkt. cap
9.42B
Avg. vol.
1.88M
Volume
607.76K
P/E ratio
89.27
52-wk high
$117.46
52-wk low
$30.08
EPS
$1.31
Shares outstanding
62.47M
No. of employees
1K
Open
$114.09
High
$117.46
Low
$113.56
Mkt. cap
9.42B
Avg. vol.
1.88M
Volume
607.76K
P/E ratio
89.27
52-wk high
$117.46
52-wk low
$30.08
EPS
$1.31
Shares outstanding
62.47M
No. of employees
1K
News stories
From web sources and news partners
Zacks
·
1 hour ago
Reasons to Hold Hinge Health Stock in Your Portfolio for Now
Yahoo Finance
·
2 hours ago
Reasons to Hold Hinge Health Stock in Your Portfolio for Now
Investing.com
·
1 day ago
Hinge Health stock reaches all-time high at 113.51 USD
About Hinge Health Inc
CEO-
Employees1.44K
Founded2012
HeadquartersSan Francisco, California, United States
SectorHealth care provider
Websitehingehealth.com
Analyst ratings
Based on 14 analysts giving stock ratings to HNGE in the past 3 months
Strong buy
Buy
13
Hold
1
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for HNGE in the last 3 months.
Highest
Current $116.79
$140.00 (+19.87%)
Average
$112.00 (-4.10%)
Lowest
$90.00 (-22.94%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
David Grossman Stifel Nicolaus | Buy | Maintained | $130.00 | +11.3% | 10/26/2026 |
Tomer Zilberman Bank of America Securities | Buy | Maintained | $130.00 | +11.3% | 10/23/2026 |
Scott Schoenhaus KeyBanc | Buy | Maintained | $140.00 | +19.9% | 10/16/2026 |
Rishi Jaluria RBC Capital | Buy | Maintained | $110.00 | -5.8% | 10/15/2026 |
Craig Hettenbach Morgan Stanley | Buy | Maintained | $117.00 | +0.2% | 10/12/2026 |
Saket Kalia Barclays | Buy | Reiterated | $110.00 | -5.8% | 10/12/2026 |
Terry Tillman Truist Financial | Buy | Maintained | - | - | 09/28/2026 |
Vikram Kesavabhotla Robert W. Baird | Hold | Maintained | $90.00 | -22.9% | 09/22/2026 |
Jailendra Singh Truist Financial | Buy | Reiterated | $112.00 | -4.1% | 08/11/2026 |
Eugene Mannheimer Freedom Capital Markets | Buy | Reiterated | $103.00 | -11.8% | 08/10/2026 |
Richard Close Canaccord Genuity | Buy | Reiterated | $105.00 | -10.1% | 08/05/2026 |
Aaron Kimson Citizens JMP | Buy | Maintained | $107.00 | -8.4% | 08/05/2026 |
Ryan MacDonald Needham | Buy | Reiterated | $97.00 | -16.9% | 08/05/2026 |
Ryan Daniels William Blair | Buy | Maintained | - | - | 08/04/2026 |
Elizabeth Anderson CFA Evercore ISI | Buy | Maintained | $105.00 | -10.1% | 08/04/2026 |
Stan Berenshteyn Wells Fargo | Buy | Reiterated | $90.00 | -22.9% | 06/24/2026 |
Brian Peterson Raymond James | Buy | Maintained | $80.00 | -31.5% | 06/15/2026 |
Jessica Tassan Piper Sandler | Buy | Maintained | $95.00 | -18.7% | 05/06/2026 |
Kenneth Herbert RBC Capital | Buy | Maintained | $55.00 | -52.9% | 03/10/2026 |
Bradley Sills Bank of America Securities | Buy | Maintained | $64.00 | -45.2% | 02/10/2026 |
Next call in 4 days
Mon, Nov 2, 4:30 PM
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / $0.60
Revenue / Est. (USD)
- / 224.78M
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 154.21M | 170.73M | 182.31M | 212.82M |
Cost of goods sold | 27.97M | 26.55M | 27.97M | 28.82M |
Cost of revenue | 27.97M | 26.55M | 27.97M | 28.82M |
Research and development expenses | 31.92M | 32.76M | 29.64M | 34.06M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 100.37M | 84.02M | 91.13M | 109.45M |
Operating expense | 132.33M | 116.92M | 122.27M | 143.55M |
Total operating expenses | 160.30M | 143.47M | 150.24M | 172.38M |
Operating income | -6.09M | 27.26M | 32.07M | 40.44M |
Other non operating income | -5.00K | 166.00K | -77.00K | 115.00K |
EBT including unusual items | -1.64M | 32.22M | 35.94M | 44.43M |
EBT excluding unusual items | -1.64M | 32.22M | 35.94M | 44.43M |
Income tax expense | 206.00K | 122.00K | 814.00K | 740.00K |
Effective tax rate | -12.58% | 0.38% | 2.26% | 1.67% |
Other operating expenses | 40.00K | 147.00K | 1.50M | 45.00K |
Net income | -1.84M | 32.10M | 35.13M | 43.69M |
Net profit margin | -1.20% | 18.80% | 19.27% | 20.53% |
Earnings per share | 0.44 | 0.49 | 0.45 | 0.59 |
Interest and investment income | 4.46M | 4.80M | 3.95M | 3.88M |
Interest expense | - | - | - | - |
Net interest expenses | 4.46M | 4.80M | 3.95M | 3.88M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | -5.53M | 27.78M | 32.54M | 40.90M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events